Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.
about
Understanding the population genetics of Plasmodium vivax is essential for malaria control and eliminationIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialA high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings.Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivoContrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and EliminationGenetic diversity and population structure of Plasmodium vivax in Central ChinaReactive Case Detection for Plasmodium vivax Malaria Elimination in Rural Amazonia.High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping.Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infectionsPCR-RFLP for Rapid Subtyping of Plasmodium vivax Korean Isolates.How much remains undetected? Probability of molecular detection of human Plasmodia in the fieldStrategies for designing and monitoring malaria vaccines targeting diverse antigensEpidemiology of disappearing Plasmodium vivax malaria: a case study in rural AmazoniaMultiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New GuineaGlobal extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.Global and local genetic diversity at two microsatellite loci in Plasmodium vivax parasites from Asia, Africa and South America.Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands.Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infectionDrug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria.Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemiaA Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific.Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania.Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia.Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern EthiopiaExpression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years.Microsatellite Genotyping of Plasmodium vivax Isolates from Pregnant Women in Four Malaria Endemic Countries.Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiologyWhere chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnelMolecular Monitoring of Plasmodium vivax Infection after Radical Treatment in Southeastern IranMolecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.Genotype comparison of Plasmodium vivax and Plasmodium falciparum clones from pregnant and non-pregnant populations in North-west Colombia.Genetic diversity among Plasmodium vivax isolates along the Thai-Myanmar border of ThailandGenotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection.Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers.Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico
P2860
Q17485678-826AF540-535D-4030-8850-A897FDBE811EQ28481649-1388D44E-E142-4237-A30B-CA5006D90722Q28539392-857F20AC-D6EF-4ABC-8FC4-AC58BA177B42Q28544459-91E6BA7E-D1AD-45AB-83A1-C5DF81292E4AQ28547081-6B5C1D28-E053-4699-9028-A80EBC407683Q28655779-AE0C803C-232A-4114-A978-AAFFA09F3771Q30379318-2140632F-9055-4218-8132-42ADC83E2F01Q33617549-05F84775-DC87-4C17-93A4-4306665DE83CQ33674933-45BBF555-A388-477B-B89E-08870594B48DQ33745543-9D0D41E4-FB3F-4227-ADB2-6807224937C0Q33892663-8A957498-5689-437D-9BB5-95EA528DF455Q33959038-1CABDAB8-76AA-429F-8535-10CA54886FB9Q34104487-49B74BB4-3B55-46AD-9897-40A39C0B9249Q34113806-D4387627-7F4E-481C-9FBA-E1A19DB0ABB3Q34259032-923DF7C7-3BD4-4E51-95F1-EE0594CCB0B8Q34354870-96342F01-8BFE-44D6-AC02-12AC5EEDFE9AQ34465321-F9E78C49-B267-4851-AB1E-4AC2E949FEE4Q34490613-E3897352-03D4-48AB-B6A8-0D02FC87FD20Q34531112-4409C0AE-7CC0-46DF-811A-353A4A09BF7BQ34675111-EA21D12D-0FF1-4278-8423-D7E41225C254Q34792787-76B5A984-0DBF-4DC1-805A-14AB575D9546Q35052724-B55FD077-B6C0-41C9-B634-FDB0BCDA877DQ35072841-F9670C7F-600E-4033-8251-4F520046A664Q35191546-1867F00A-4174-417D-9EDB-A63FB4D0D945Q35338795-02A1B262-1719-48EB-8B31-2EFFBDC4F079Q35807931-C833E7CC-81CE-47CE-8894-6670EDDCF894Q35829555-F7630936-5DCF-46BF-AE67-C10743DE27F3Q35962523-3D9A0F6C-0699-4EAF-8748-1D29FB07D6C1Q35969188-F962A98A-F95D-4910-AFC3-7D235F9BAB9AQ35994181-390BA825-0807-4470-85D0-32D7093F2D96Q36017165-F8DB7F8A-D75F-4D86-BC32-1C66D4869393Q36024954-7B4F8030-0E9C-4FAB-ACF1-E8F1A65647D7Q36064945-E7D4E0CA-505D-476D-A1EC-09EF6E6674C1Q36187618-2AF23267-3631-4A4A-A6C1-5D480FCEB299Q36232661-5B74788A-2722-45C8-B7EA-97E5E41B68D0Q36459513-5190F28F-2274-4ABD-A8B8-889AFE9F9A89Q36560648-2A276B0B-C610-4819-8CE8-1C1917A923DDQ36616425-FEF41843-1DDE-4DA7-BAAF-E9C258B778C5Q36697864-45DB51FF-3292-40BE-A52B-4FE6C6FA8811Q36798238-5C47DF54-3EE8-473E-B0CE-8FCE2D60C375
P2860
Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@en
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@nl
type
label
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@en
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@nl
prefLabel
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@en
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@nl
P2093
P50
P356
P1476
Evaluation of Plasmodium vivax ...... monitoring in clinical trials.
@en
P2093
Albert Sie
Jutta Marfurt
Mary Goroti
P304
P356
10.1086/597303
P407
P577
2009-04-01T00:00:00Z